Global Hemostat Powder Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Hemostat Powder market size will reach 476.18 Million USD in 2025 and is projected to reach 636.81 Million USD by 2032, with a CAGR of 4.24% (2025-2032). Notably, the China Hemostat Powder market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Hemostat powder refers to a medical substance designed to promote hemostasis, which is the process of stopping bleeding. Hemostat powders are typically composed of hemostatic agents, such as absorbable materials or active ingredients that facilitate blood clotting. These powders are applied directly to bleeding wounds or surgical sites to accelerate the clotting process and control hemorrhage. The hemostatic powder absorbs excess moisture, adheres to the bleeding surface, and promotes the formation of a stable blood clot, effectively halting bleeding. Hemostat powders are commonly used in various surgical and medical settings, particularly in cases where traditional methods of hemostasis, such as sutures or pressure, may be challenging or insufficient. The convenience and effectiveness of hemostat powders make them valuable tools in managing bleeding and enhancing hemostasis during medical interventions.

The major global  manufacturers of Hemostat Powder include Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring, Gelita Medical, Ferrosan Medical Devices, Baxter, Equimedical, Celox, Medira, Biocer, Hemostasis, MBP, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Hemostat Powder. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Hemostat Powder market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Hemostat Powder market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Hemostat Powder industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Hemostat Powder Include:

Johnson & Johnson

C. R. Bard

Pfizer

CSL Behring

Gelita Medical

Ferrosan Medical Devices

Baxter

Equimedical

Celox

Medira

Biocer

Hemostasis

MBP

Hemostat Powder Product Segment Include:

Gelatin

Fibrin

Cellulose

Others

Hemostat Powder Product Application Include:

Surgical Wound Care

General Wound Care

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Hemostat Powder Industry PESTEL Analysis

Chapter 3: Global Hemostat Powder Industry Porter's Five Forces Analysis

Chapter 4: Global Hemostat Powder Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Hemostat Powder Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Hemostat Powder Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Hemostat Powder Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources